biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Response to fuzzy, and for everybody else, too

<< Previous

Bullboard Posts

Next >>

Comment by fuzzyjron Aug 21, 2023 6:28pm

99 Views

Post# 35598845

RE:Response to fuzzy, and for everybody else, too

Get yourself a good lawyer & one friend with cash mr know it all.

Surely a man with your knowledge, many theories & what you believe to be a solid case of wrong doing/corruption/fraud you shouldn't have a problem bringing the truth to light. Heck with all your ammo/facts surely a firm would do a pro bono deal with a fella holding on to all this so called
evidence of yours

All it looks like your doing here so far is slandering the ceo of Bti over & over again based on your fiction type theories. Put some
teeth in it & move forward with a law suit or zip it.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario